Topical medical therapy remains the conventional initial intervention for open-angle glaucoma and ocular hypertension. However, chronic exposure to topical formulations laden with preservatives frequently compromises the ocular surface and adjacent anterior segment structures. Recent clinical investigations indicate that cumulative chemical exposure significantly influences surgical outcomes. Specifically, evaluating how long-term medication regimens affect ab-interno trabeculotomy helps ophthalmologists refine preoperative management and optimize long-term intraocular pressure reduction.

Understanding the Preservative Burden Index in Glaucoma Care

Clinicians historically assessed topical drop toxicity primarily through qualitative symptoms or the total daily drop count. However, this approach ignores varying preservative concentrations across different commercial formulations. The Preservative Burden Index addresses this discrepancy by quantifying cumulative exposure based on specific concentrations and daily frequencies of preservatives such as benzalkonium chloride.

Benzalkonium chloride acts as a quaternary ammonium detergent that disrupts bacterial cell walls to maintain bottle sterility. Unfortunately, this detergent action similarly damages human ocular tissues. When patients instill multiple preserved drops daily over many years, the toxic load progressively accumulates within corneal, conjunctival, and trabecular tissues.

Calculating a structured index allows surgeons to stratify patient risk before performing angle-based procedures. Consequently, eye care specialists can determine whether intense medical regimens might impair surgical success. Incorporating this quantitative metric into routine clinical practice enables precise documentation of chronic chemical toxicity. Therefore, ophthalmologists can make informed surgical decisions rather than relying on crude medication counts.

Mechanisms of Preservative Toxicity and Surgical Outflow Resistance

The adverse effects of topical preservatives extend far beyond superficial ocular surface irritation. Benzalkonium chloride induces chronic subclinical inflammation, goblet cell loss, and progressive epithelial apoptosis. Furthermore, clinical and histological evidence shows that preservative molecules penetrate the anterior chamber and accumulate within conventional outflow pathways.

In the trabecular meshwork, persistent preservative exposure triggers oxidative stress, cytokine release, and localized tissue remodeling. This chronic chemical insult accelerates extracellular matrix deposition and stiffens the collector channel ostia. Consequently, the distal aqueous outflow pathways lose their natural compliance and filtration capacity.

Traditional filtration surgeries, such as trabeculectomy, fail largely due to subconjunctival fibrosis driven by this preservative-induced inflammatory cascade. Similarly, angle-based procedures depend heavily on the functional patency of collector channels and episcleral veins downstream of Schlemm canal. When chronic preservative exposure induces deep tissue fibrosis, removing trabecular resistance alone cannot fully restore normal aqueous drainage. Therefore, preoperative preservative toxicity directly threatens angle surgery efficacy.

Comparing Surgical Outcomes of KDB and GATT

Minimally invasive angle procedures offer distinct surgical approaches to relieve trabecular outflow resistance. Kahook Dual Blade excises a precise strip of the trabecular meshwork to expose collector channels directly. In contrast, gonioscopy-assisted transluminal trabeculotomy achieves a full 360-degree circumferential unroofing of Schlemm canal.

Recent comparative studies evaluate how preoperative preservative burdens differentially impact these two interventions. Clinical data reveal that patients undergoing gonioscopy-assisted transluminal trabeculotomy frequently present with significantly higher baseline preservative loads than those selected for dual-blade goniotomy. This disparity occurs because clinicians often reserve circumferential trabeculotomy for advanced glaucoma cases requiring aggressive prior medical therapy.

Despite differences in surgical extent, both techniques require intact downstream outflow channels to achieve sustained intraocular pressure control. When distal pathways suffer from extensive preservative-induced sclerosis, neither circumferential nor focal trabeculotomy can guarantee complete success. Therefore, identifying patient-specific risk profiles through comprehensive preoperative evaluations remains essential for selecting the optimal angle procedure.

Impact of Preoperative Preservatives on Ab-Interno Trabeculotomy

Rigorous clinical evidence demonstrates a direct correlation between high preservative exposure and surgical failure following ab-interno trabeculotomy. Multivariable Cox regression analyses identify elevated preservative burden scores as independent predictors of surgical failure at one year.

Receiver operating characteristic analyses have identified critical preservative exposure thresholds that distinguish high-risk patients from optimal surgical candidates. When cumulative exposure exceeds this threshold, the one-year complete and qualified success rates drop markedly. Elevated preservative loads promote persistent postoperative intraocular inflammation, leading to premature closure of the surgically created trabecular cleft.

Moreover, patients with extensive preservative exposure often experience transient intraocular pressure spikes and hyphema clearance delays. These postoperative complications further stimulate fibroblast proliferation and fibrotic scarring along the canal floor. Consequently, surgeons must recognize that extensive preoperative medical therapy compromises the surgical bed before the first incision is made. Addressing this chemical burden proactively can substantially improve operative outcomes.

Clinical Strategies to Mitigate Preservative Toxicity

Ophthalmologists should implement active measures to minimize preservative toxicity well before surgical intervention. Transitioning patients to preservative-free drop formulations represents an effective first step. Preservative-free prostaglandin analogues, beta-blockers, and carbonic anhydrase inhibitors effectively lower intraocular pressure while eliminating toxic chemical exposure.

Additionally, selective laser trabeculoplasty offers a viable non-pharmacologic alternative that reduces topical medication dependence. By performing laser trabeculoplasty early in the disease course, clinicians can lower intraocular pressure without subjecting ocular tissues to chronic detergents. Fixed-combination therapies also help decrease cumulative preservative exposure by reducing daily drop instillation frequency.

Furthermore, introducing short courses of unpreserved topical anti-inflammatory agents prior to surgery can stabilize the compromised ocular surface. Managing coexisting meibomian gland dysfunction and dry eye disease with artificial tears and punctal plugs also reduces localized tissue stress. Consequently, preparing the eye prior to surgery restores tissue homeostasis and enhances postoperative aqueous outflow.

Optimizing Preoperative Protocols for Minimally Invasive Glaucoma Surgery

Establishing standardized preoperative protocols is paramount for maximizing success in modern angle surgery. Glaucoma specialists should routinely audit the chemical composition and preservative concentration of all topical agents prescribed to patients. Documenting cumulative drop exposure enables accurate stratification of operative risk.

When surgery becomes necessary, moving toward early intervention rather than exhaustive medical escalation prevents irreversible distal outflow sclerosis. Prolonged medical therapy using three or four preserved agents inadvertently damages the very structures required for angle surgery success. Therefore, timely surgical referral preserves collector channel function and improves long-term intraocular pressure outcomes.

Moreover, post-surgical management must avoid re-introducing preserved topical medications whenever possible. Resuming preserved drops during the postoperative recovery phase can trigger recurrent inflammation and accelerate canal closure. By combining preservative-free perioperative regimens with precise surgical execution, ophthalmologists can achieve optimal, durable pressure control and protect patient visual fields.

How does preoperative preservative exposure affect ab-interno trabeculotomy outcomes?

Preoperative exposure to topical preservatives, particularly benzalkonium chloride, causes chronic subclinical inflammation and tissue remodeling within the trabecular meshwork and downstream collector channels. This chemical burden damages distal aqueous outflow pathways and increases fibrotic healing after surgery. Consequently, patients with high cumulative preservative exposure experience lower one-year complete and qualified success rates, higher risk of postoperative pressure spikes, and increased incidence of surgical failure following angle-based procedures.

What is the Preservative Burden Index and how is it used in clinical practice?

The Preservative Burden Index is a quantitative clinical metric calculated by evaluating the specific concentrations and daily frequencies of topical preservatives in a patient's regimen. Unlike simple drop counting, this index accurately reflects cumulative chemical toxicity on ocular tissues. Surgeons use receiver operating characteristic cut-offs from the index to identify high-risk individuals, determine optimal surgical timing, and modify preoperative treatment regimens before performing angle interventions.

How can ophthalmologists reduce preservative-related surgical risks in glaucoma patients?

Ophthalmologists can mitigate preservative-related surgical risks by transitioning patients to preservative-free ocular hypotensive formulations, utilizing fixed-combination eye drops, or performing early selective laser trabeculoplasty to reduce drop dependence. Additionally, treating underlying ocular surface disease and administering unpreserved topical anti-inflammatory therapy before surgery calms localized tissue inflammation. Finally, avoiding prolonged maximal medical therapy preserves the structural integrity and functionality of distal aqueous outflow pathways.

Disclaimer: This content is for informational and educational purposes only... Refer to the latest local and national guidelines for clinical practice.

References

1. Temel B et al. The Effect of Preoperative Preservative Burden on the Success of Ab-Interno Trabeculotomy. Semin Ophthalmol. 2026 Aug 23. doi: 10.1080/08820538.2026.2716933. PMID: 42633590.
2. Baudouin C, Labbé A, Liang H, Pauly A, Brignole-Baudouin F. Preservatives in eyedrops: the good, the bad and the ugly. Prog Retin Eye Res. 2010;29(4):312-334.
3. Broadway DC, Grierson I, O'Brien C, Hitchings RA. Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery. Arch Ophthalmol. 1994;112(11):1446-1454.
4. Agnifili L, Fasanella V, Mastropasqua R, et al. In vivo confocal microscopy of the ocular surface in glaucoma patients: an overview. Ophthalmol Ther. 2016;5(1):1-14.